,i #aadth ,,congress #ast ,session ,h4 ,r4 #cgai ,,in ,,the ,,house ,,of ,,representatives ,october #h1 #bjae ,mr4 ,guinta 7for himself and ,ms4 ,kuster7 introduced the following bill2 which was referred to the ,committee on the ,judiciary1 and in addition to the ,committee on ,energy and ,commerce1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to provide for the comprehensive approach to eradication of the heroin epidemic1 to develop the best practices in law enforcement and prescription medication prescribing practices1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,stop the ,overdose ,problem ,already ,becoming a ,universal ,substance ,epidemic ,act of #bjae or the ,,stop ,,abuse ,act of #bjae4 #b4 ,findings ,congress finds the following3 7#a7 ,prevention and intervention are the best investment4 7#b7 ,according to the #bjab ,national ,survey on ,drug ,usage and ,health1 the percent of ,new ,hampshire residents #ab and older reporting ever having used heroin has doubled since #bjjd1 #a4b percent in #bjje and #c4c percent in #bjaa4 7#c7 ,the number of patients in ,new ,hampshire admitted to ,state-funded treatment programs for heroin reached #a1edj in #bjac1 a major increase from the #hje reported in #bjjd4 7#d7 ,prescription opioid users admitted rose from #bac in #bjjd to #a1big in #bjac4 7#e7 ,drug poisoning 7more commonly called overdose7 is the number one cause of injury-related death in the ,united ,states and deaths involving heroin have been on a steady increase in recent years4 7#f7 ,in #bjab1 #bh ,states reported that the death rate for heroin overdose had doubled from #bjaj through #bjab4 7#g7 ,the increase doubled from #a4b percent to #b4a percent per #ajj1jjj population1 reflecting the number of deaths having increased from #a1ggi to #c1fce4 7#h7 ,the number of drug-poisoning deaths involving heroin was nearly four times higher for men 7#f1ebe deaths7 than women 7#a1gcb deaths7 in #bjac4 7#i7 ,the rate of heroin-related overdoses was highest among adults aged #be to #dd from #bjjj through #bjac2 this is a #b4h-percent increase from #a4i to #e4d4 7#aj7 ,in #bjac1 the ,midwest and ,northeast regions had higher rates 7#d4c and #c4i per #ajj1jjj1 respectively74 ,from #bjjj through #bjac1 the age-adjusted rate for heroin-related drug-poisoning deaths increased in the ,midwest region exponentially 7from #j4d to #d4c per #ajj1jjj71 increased more than #d-;fold in the ,northeast region 7from #j4i to #c4i71 increased more than #c-;fold in the ,south region 7from #j4e to #a4g71 and doubled in the ,west region 7from #j4i to #a4h74 7#aa7 ,the greatest increase for drug-poisoning rates was seen in the ,midwest region4 #c4 ,development of best practices 7a7 ,interagency ,task ,force ,not later than #abj days after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services 7referred to in this section as the ,secretary71 in cooperation with the ,secretary of ,veterans ,affairs1 the ,secretary of ,defense1 the ,administrator of the ,drug ,enforcement ,administration1 the ,secretary of ,homeland ,security1 and the ,attorney ,general of the ,united ,states1 shall convene an ,interagency ,task ,force to ,address ,opioid ,abuse 7referred to in this section as the ,task ,force74 7b7 ,membership ,the ,task ,force shall-- 7#a7 be comprised of two representatives of each the ,department of ,health and ,human ,services1 including the ,centers for ,disease ,control and ,prevention1 the ,department of ,veterans ,affairs1 the ,department of ,defense1 the ,drug ,enforcement ,administration1 the ,office of ,national ,drug ,control ,policy1 the ,national ,academy of ,medicine1 the ,national ,institutes of ,health1 the ,indian ,health ,service1 the ,department of ,homeland ,security1 and the ,substance ,abuse and ,mental ,health ,services ,administration2 and 7#b7 include physicians1 dentists1 non-physician prescribers1 pharmacists1 experts in the fields of pain research and addiction research1 and representatives of the mental health treatment community1 the addiction treatment community1 and pain advocacy groups4 7c7 ,duties 7#a7 ,best practices ,not later than #ahj days after the date on which the ,task ,force is convened1 the ,task ,force shall-- 7,a7 develop best practices for pain management and prescription medication prescribing practices1 taking into consideration recommendations from-- 7i7 relevant conferences2 7ii7 ongoing efforts at the ,state and local levels2 and 7iii7 medical professional organizations to develop improved pain management strategies2 7,b7 solicit and take into consideration public comments on the best practices developed under subparagraph 7,a72 7,c7 develop a strategy for disseminating information about the best practices under subparagraph 7,a7 to all medical and emergency personnel who enforce1 prescribe1 and treat opioid and heroin addiction2 and 7,d7 conduct a study on the feasibility of implementing the best practices developed under subparagraph 7,a74 7#b7 ,report to ,congress ,not later than #bgj days after the date on which the ,task ,force is convened1 the ,task ,force shall submit to the ,congress a report that includes-- 7,a7 the strategy under paragraph 7#a77;,c7 for disseminating the best practices under paragraph 7#a77;,a72 7,b7 the results of the feasibility study conducted under paragraph 7#a77;,d72 and 7,c7 recommendations on how to apply such best practices to improve prescribing practices at medical facilities1 including medical facilities of the ,veterans ,health ,administration4 7d7 ,no rulemaking authority ,the ,task ,force shall not have rulemaking authority4 #d4 ,community-based coalition enhancement grants to address local drug crises ,title ,i of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh 7#db ,u4,s4,c4 #cgaa et seq47 is amended by adding at the end of the following3 ,,ll ,grants to combat drug crises and incarceration related to drug use #cjba4 ,community-based coalition to address local drug crises 7a7 ,definitions ,in this section3 7#a7 ,drug-,free ,communities ,act of #aiig ,the term ,drug-,free ,communities ,act of #aiig means chapter #b of the ,national ,narcotics ,leadership ,act of #aihh 7#ba ,u4,s4,c4 #aeba et seq472 7#b7 ,eligible entity ,the term eligible entity means an eligible coalition 7as such term is defined under section #ajbc of the ,drug-,free ,communities ,act of #aiig 7#ba ,u4,s4,c4 #aebc77 that-- 7,a7 on or before the date of submitting an application for a grant under this section1 received a grant under the ,drug-,free ,communities ,act of #aiig2 and 7,b7 has demonstrated that there is a local drug crisis in the area serviced by the entity1 as determined by the ,attorney ,general based on the ,monitoring ,future ,survey published by the ,national ,institute on ,drug ,abuse and the ,national ,survey on ,drug ,use and ,health by the ,substance ,abuse and ,mental ,health ,service ,administration4 7#c7 ,local drug crisis ,the term local drug crisis means1 with respect to the area serviced by an eligible entity-- 7,a7 a sudden increase in the abuse of opioids1 as documented by local data2 or 7,b7 the abuse of prescription medications1 specifically opioids1 that is significantly higher than the national average1 over a sustained period of time1 as documented by local data4 7b7 ,program authorized ,the ,attorney ,general1 in coordination with the ,director of the ,national ,institute on ,drug ,abuse and the ,administrator of the ,substance ,abuse and ,mental ,health ,services ,administration1 may make grants to eligible entities to implement comprehensive1 community-wide strategies that address local drug crises within the area served by the eligible entity4 7c7 ,application 7#a7 ,in general ,an eligible entity desiring a grant under this section shall submit an application to the ,attorney ,general at such time1 in such manner1 and accompanied by such information as the ,attorney ,general may require4 7#b7 ,criteria ,as part of an application for a grant under this section1 the ,attorney ,general shall require an eligible entity to submit a detailed comprehensive1 multi-sector plan for addressing the local drug crisis within the area served by the eligible entity4 7d7 ,use of ,funds ,an eligible entity shall use a grant received under this section-- 7#a7 for programs designed to implement comprehensive1 community-wide prevention strategies to address the local drug crisis in the area served by the eligible entity1 in accordance with the plan submitted under subsection 7c77#b72 and 7#b7 to obtain specialized training and technical assistance from the ,national ,community ,antidrug ,coalition ,institute4 7e7 ,grant ,amounts and ,duration 7#a7 ,amounts ,the ,attorney ,general may not award a grant under this section for a fiscal year in an amount that exceeds-- 7,a7 the amount of non-,federal funds raised by the eligible entity1 including in-kind contributions1 for that fiscal year2 or 7,b7 #ge1jjj4 7#b7 ,duration ,the ,attorney ,general may not award a grant under this section for a period exceeding #d years4 7f7 ,supplement ,not ,supplant ,an eligible entity shall use ,federal funds received under this section only to supplement funds that would1 in the absence of those ,federal funds1 be made available from other ,federal and non-,federal sources for the activities described in this section1 and not to supplant those funds4 7g7 ,evaluation ,a grant under this section shall be subject to the same evaluation requirements and procedures as the evaluation requirements and procedures imposed on the recipient of a grant under the ,drug-,free ,communities ,act of #aiig4 7h7 ,limitation on ,administrative ,expenses ,not more than #h percent of the amounts made available to carry out this section for a fiscal year may be used by the ,attorney ,general to pay for administrative expenses4 7i7 ,authorization of appropriations ,there is authorized to be appropriated to carry out this section #e1jjj1jjj for each of fiscal years #bjaf through #bjbj4 4 #e4 ,limitations on civil liability for certain individuals working at opioid overdose programs 7a7 ,limitation on civil liability for individuals working for or volunteering at a ,state or local agency opioid overdose program 7#a7 ,in general ,notwithstanding any other provision of law1 except as provided in paragraph 7#b71 no individual who provides an opioid overdose drug shall be liable for harm caused by the emergency administration of an opioid overdose drug by another individual if the individual who provides such drug-- 7,a7 works for or volunteers at an opioid overdose program2 and 7,b7 provides the opioid overdose drug as part of the opioid overdose program to an individual authorized by the program to receive an opioid overdose drug4 7#b7 ,exception ,paragraph 7#a7 shall not apply if the harm was caused by the gross negligence or reckless misconduct of the individual who provides the drug4 7b7 ,limitation on civil liability for individuals who administer opioid overdose drugs 7#a7 ,in general ,notwithstanding any other provision of law1 except as provided in paragraph 7#b71 no individual shall be liable for harm caused by the emergency administration of an opioid overdose drug to an individual who has or reasonably appears to have suffered an overdose from heroin or another opioid1 if-- 7,a7 the individual who administers the opioid overdose drug-- 7i7 obtained the drug from a health care professional or as part of an opioid overdose program2 or 7ii7 administers the drug pursuant to a prescription for an opioid overdose drug that is approved or licensed under section #eje of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cee7 or is licensed under section #cea of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bfb72 and 7,b7 the individual who administers the opioid overdose drug was educated on-- 7i7 when to administer the drug2 7ii7 how to administer the drug2 and 7iii7 steps to be taken after the drug is administered4 7#b7 ,exception ,paragraph 7#a7 shall not apply to an individual if the harm was caused by the gross negligence or reckless misconduct of the individual who administers the drug4 7c7 ,preemption and election of ,state nonapplicability 7#a7 ,preemption ,except as provided in paragraph 7#b71 this section preempts the law of a ,state to the extent that such law is inconsistent with this section1 except that this section shall not preempt any ,state law that provides additional protection from liability relating to the administration of opioid overdose drugs or that shields from liability any person who provides or administers opioid overdose drugs4 7#b7 ,election of ,state regarding nonapplicability ,subsections 7a7 and 7b7 shall not apply to any civil action in a ,state court against a person who administers opioid overdose drugs if-- 7,a7 all parties to the civil action are citizens of the ,state in which such action is brought2 and 7,b7 the ,state enacts legislation in accordance with ,state requirements for enacting legislation-- 7i7 citing the authority of this paragraph2 7ii7 declaring the election of the ,state that such subsections 7a7 and 7b7 shall not apply1 as of a date certain1 to any civil actions covered by this section2 and 7iii7 containing no other provisions4 7d7 ,definitions ,in this section -- 7#a7 the term health care professional means a person licensed by a ,state to prescribe prescription drugs2 7#b7 the term opioid overdose drug means a drug that1 when administered1 reverses in whole or part the pharmacological effects of an opioid overdose in the human body2 and 7#c7 the term opioid overdose program means a program operated by a local health department1 community-based organization1 substance abuse treatment organization1 law enforcement agency1 fire department1 other first responder department1 or voluntary association or a program funded by a ,federal1 ,state1 or local government that works to prevent opioid overdoses by in part providing opioid overdose drugs and education to individuals at risk of experiencing an opioid overdose or to an individual in a position to assist another individual at risk of experiencing an opioid overdose4 #f4 ,operation of opioid treatment programs ,section #cjc of the ,controlled ,substances ,act 7#ba ,u4,s4,c4 #hbc7 is amended by adding at the end the following3 7i7 7#a7 ,an opioid treatment program that is registered under this section1 and that closes for business on any weekday or weekend day1 including a ,federal or ,state holiday1 shall comply with the requirements of this subsection4 7#b7 ,for each patient who is restricted by a ,federal regulation or guideline or by the determination of the program medical director from having a take-home dose of a controlled substance related to the treatment involved1 the program shall make acceptable arrangements for the patient to receive a dose of that substance under appropriate supervision during the closure4 7#c7 ,the ,administrator of the ,substance ,abuse and ,mental ,health ,services ,administration shall issue a notice that references regulations on acceptable arrangements under this subsection1 or shall promulgate regulations on such acceptable arrangements4 4 #g4 ,treatment alternative to incarceration programs ,part ,,ll of the ,omnibus ,crime ,control and ,safe ,streets ,act of #aifh1 as added by section #c1 is amended by adding at the end the following3 #cjbb4 ,treatment alternative to incarceration programs 7a7 ,definition ,in this section3 7#a7 ,the term eligible entity means a ,state1 unit of local government1 ,indian tribe1 or nonprofit organization4 7#b7 ,the term eligible participant means an individual who-- 7,a7 comes in contact with the juvenile justice system or criminal justice system or is arrested or charged with an offense2 7,b7 has a history of or a current-- 7i7 substance use disorder2 7ii7 mental illness2 or 7iii7 co-occurring mental illness and substance use disorder2 and 7,c7 has been approved for participation in a program funded under this section by the relevant law enforcement agency1 prosecuting attorney1 defense attorney1 probation or corrections official1 judge1 or representative from the relevant mental health or substance abuse agency1 as applicable4 7b7 ,program authorized ,the ,attorney ,general may make grants to eligible entities to develop1 implement1 or expand a treatment alternative to incarceration programs for eligible participants1 including-- 7#a7 programs for use before the filing of criminal charges against an individual1 which shall include-- 7,a7 training for law enforcement officers on substance use disorders1 mental illness1 and co-occurring mental illness and substance use disorders2 7,b7 the use of receiving centers as alternatives to incarceration of eligible participants2 7,c7 the use of specialized response units for calls related to substance use disorders1 mental illness1 and co-occurring mental illness and substance use disorders2 and 7,d7 other arrest and pre-booking treatment alternative to incarceration models2 and 7#b7 programs for use after the filing of criminal charges against an individual1 which shall include-- 7,a7 specialized clinical case management2 7,b7 pre-trial services related to substance use disorders1 mental illness1 and co-occurring mental illness and substance use disorders2 7,c7 prosecutor and defense-based programs2 7,d7 specialized probation2 7,e7 programs utilizing the ,american ,society of ,addition ,medicine patient placement criteria2 7,f7 treatment and rehabilitation programs and recovery support services2 and 7,g7 drug courts1 ,,dwi courts1 and veterans treatment courts4 7c7 ,application 7#a7 ,in ,general ,an eligible entity seeking a grant under this section shall submit an application to the ,attorney ,general that meets the criteria in paragraph 7#b7 at such time1 in such manner1 and accompanied by such additional information as the ,attorney ,general may reasonably require4 7#b7 ,criteria ,an eligible entity1 in submitting an application under paragraph 7#a71 shall provide evidence that the entity1 with regard to the alternative to incarceration program for which it seeks funds under this section-- 7,a7 has collaborated or will collaborate with the ,state and local government agencies overseeing health1 community corrections1 courts1 prosecution1 substance abuse1 mental health1 victims services1 and employment services1 and with local law enforcement agencies2 7,b7 has consulted or will consult with the ,state authority for substance abuse2 7,c7 will use evidence-based screening and assessment treatment practices2 7,d7 will use evidence-based screening and assessment tools to place participants in the treatment alternative to the incarceration program2 and 7,e7 will use evidence-based methodology and outcome measurements to evaluate the program1 and provide a description of-- 7i7 such methodology and measurements1 including how such measurements will provide valid measures of the impact of the program2 and 7ii7 how the program could be broadly replicated if demonstrated to be effective4 7d7 ,requirements ,an eligible entity awarded a grant for a treatment alternative to incarceration program under this section shall-- 7#a7 determine the terms and conditions under which eligible participants may participate in the program1 taking into consideration the collateral consequences of an arrest1 prosecution1 or criminal conviction2 7#b7 ensure that each substance abuse and mental health treatment component of the program is licensed and qualified by the relevant jurisdiction2 7#c7 organize an enforcement unit of the program comprised of appropriately trained law enforcement professionals who are supervised by the ,state1 tribal1 or local criminal justice agency involved in the administration of the program1 the duties of which shall include-- 7,a7 the verification of addresses and other contacts of each eligible participant who participates or seeks to participate in the program2 and 7,b7 if necessary1 the location1 apprehension1 arrest1 and return to court of an eligible participant in the program who has absconded from the facility of a treatment provider or has otherwise violated the terms and conditions of the program1 consistent with ,federal and ,state confidentiality requirements2 7#d7 notify the relevant criminal justice entity if any eligible participant in the program absconds from the facility of the treatment provider or otherwise violates the terms and conditions of the program1 consistent with ,federal and ,state confidentiality requirements2 and 7#e7 submit periodic reports on the progress of treatment or other measured outcomes from participation in the program of each eligible offender participating in the program to the relevant ,state1 tribal1 or local criminal justice agency1 consistent with ,federal and ,state confidentiality requirements4 7e7 ,use of funds ,an eligible entity shall use a grant received under this section for the costs of the treatment alternative to incarceration program1 including-- 7#a7 salaries1 personnel costs1 equipment costs1 and other costs directly related to the operation of the program1 including the enforcement unit2 7#b7 payments for treatment providers that are approved by the relevant ,state or tribal jurisdiction and licensed1 if necessary1 to provide needed treatment to eligible offenders participating in the program1 including medication-assisted treatment1 aftercare supervision1 vocational training1 education1 and job placement2 and 7#c7 payments to public and nonprofit private entities that are approved by the ,state or tribal jurisdiction and licensed1 if necessary1 to provide alcohol and drug addiction treatment and mental health treatment to eligible offenders participating in the program4 7f7 ,supplement ,not ,supplant ,an eligible entity shall use ,federal funds received under this section only to supplement the funds that would1 in the absence of those ,federal funds1 be made available from other ,federal and non-,federal sources for activities described in this section1 and not to supplant those funds4 7g7 ,geographic distribution ,the ,attorney ,general shall ensure that1 to the extent practicable1 the geographical distribution of grants awarded under this section is equitable and includes a grant to an eligible entity in-- 7#a7 each ,state2 7#b7 rural1 suburban1 and urban areas2 and 7#c7 tribal jurisdictions4 7h7 ,reports and ,evaluations 7#a7 ,in ,general ,each fiscal year1 a recipient of a grant under this section during that fiscal year shall submit to the ,attorney ,general a report containing the information described in paragraph 7#b71 as well as such additional information as the ,attorney ,general may reasonably require4 ,the recipient shall submit such report in such form and on such dates as the ,attorney ,general specifies4 7#b7 ,contents ,a report submitted under paragraph 7#a7 shall-- 7,a7 describe best practices for treatment alternatives2 and 7,b7 identify training requirements for law enforcement officers who participate in treatment alternatives to incarceration programs4 7i7 ,authorization of ,appropriations ,there is authorized to be appropriated to carry out this section #aj1jjj1jjj for each of the fiscal years #bjaf through #bjbj4 4 #h4 ,reauthorization of the high intensity drug trafficking area under the office of national drug control policy ,section #gjg of the ,office of ,national ,drug ,control ,policy ,reauthorization ,act of #aiih 7#ba ,u4,s4,c4 #agjf7 is amended by striking subsection 7p7 and inserting the following3 7p7 ,authorization of appropriations ,there is authorized to be appropriated to the ,office of ,national ,drug ,control ,policy to carry out this section #bhj1jjj1jjj for each of fiscal years #bjaf through #bjbj4 4 #i4 ,reauthorization of the controlled substance monitoring program 7a7 ,amendment to purpose ,paragraph 7#a7 of section #b of the ,national ,all ,schedules ,prescription ,electronic ,reporting ,act of #bjje 7,public ,law #aji-fj7 is amended to read as follows3 7#a7 foster the establishment of ,state-administered controlled substance monitoring systems in order to ensure that-- 7,a7 health care providers have access to the accurate1 timely prescription history information that they may use as a tool for the early identification of patients at risk for addiction in order to initiate appropriate medical interventions and avert the tragic personal1 family1 and community consequences of untreated addiction2 and 7,b7 appropriate law enforcement1 regulatory1 and ,state professional licensing authorities have access to prescription history information for the purposes of investigating drug diversion and prescribing and dispensing practices of errant prescribers or pharmacists2 and 4 7b7 ,amendments to controlled substance monitoring program ,section #cii,o of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bhj;g-#c7 is amended-- 7#a7 in subsection 7a7-- 7,a7 in paragraph 7#a7-- 7i7 in subparagraph 7,a71 by striking or2 7ii7 in subparagraph 7,b71 by striking the period at the end and inserting 2 or2 and 7iii7 by adding at the end the following3 7,c7 to maintain and operate an existing ,state-controlled substance monitoring program4 2 and 7,b7 in paragraph 7#c71 by inserting by the ,secretary after ,grants awarded2 7#b7 by amending subsection 7b7 to read as follows3 7b7 ,minimum requirements ,the ,secretary shall maintain and1 as appropriate1 supplement or revise 7after publishing proposed additions and revisions in the ,federal ,register and receiving public comments thereon7 minimum requirements for criteria to be used by ,states for purposes of clauses 7ii71 7v71 7vi71 and 7vii7 of subsection 7c77#a77;,a74 2 7#c7 in subsection 7c7-- 7,a7 in paragraph 7#a77;,b7-- 7i7 in the matter preceding clause 7i71 by striking 7a77#a77;,b7 and inserting 7a77#a77;,b7 or 7a77#a77;,c72 7ii7 in clause 7i71 by striking program to be improved and inserting program to be improved or maintained2 7iii7 by redesignating clauses 7iii7 and 7iv7 as clauses 7iv7 and 7v71 respectively2 7iv7 by inserting after clause 7ii7 the following3 7iii7 a plan to apply the latest advances in health information technology in order to incorporate prescription drug monitoring program data directly into the workflow of prescribers and dispensers to ensure timely access to patients' controlled prescription drug history2 2 7v7 in clause 7iv71 as redesignated1 by inserting before the semicolon at the end and at least one health information technology system such as an electronic health records system1 a health information exchange1 or an e-prescribing system2 and 7vi7 in clause 7v71 as redesignated1 by striking public health and inserting public health or public safety2 7,b7 in paragraph 7#c7-- 7i7 by striking ,if a ,state that submits and inserting the following3 7,a7 ,in general ,if a ,state that submits 2 7ii7 by striking the period at the end and inserting and include timelines for full implementation of such interoperability4 ,the ,state shall also describe the manner in which it will achieve interoperability between its monitoring program and health information technology systems1 as allowable under ,state law1 and include timelines for implementation of such interoperability42 and 7iii7 by adding at the end the following3 7,b7 ,monitoring of efforts ,the ,secretary shall monitor ,state efforts to achieve interoperability1 as described in subparagraph 7,a74 2 7,c7 in paragraph 7#e7-- 7i7 by striking implement or improve and inserting establish1 improve1 or maintain2 and 7ii7 by adding at the end the following3 ,the ,secretary shall redistribute any funds that are so returned among the remaining grantees under this section in accordance with the formula described in subsection 7a77#b77;,b742 7#d7 in subsection 7d7-- 7,a7 in the matter preceding paragraph 7#a7-- 7i7 by striking ,in implementing or improving and all that follows through 7a77#a77;,b7 and inserting ,in establishing1 improving1 or maintaining a controlled substance monitoring program under this section1 a ,state shall comply1 or with respect to a ,state that applies for a grant under subparagraph 7,b7 or 7,c7 of subsection 7a77#a72 and 7ii7 by striking public health and inserting public health or public safety2 and 7,b7 by adding at the end the following3 7#e7 ,the ,state shall report to the ,secretary on-- 7,a7 as appropriate1 interoperability with the controlled substance monitoring programs of ,federal departments and agencies2 7,b7 as appropriate1 interoperability with health information technology systems such as electronic health records systems1 health information exchanges1 and e-prescribing systems2 and 7,c7 whether or not the ,state provides automatic1 real-time or daily information about a patient when a practitioner 7or the designee of a practitioner1 where permitted7 requests information about such patient4 2 7#e7 in subsections 7e71 7f77#a71 and 7g71 by striking implementing or improving each place it appears and inserting establishing1 improving1 or maintaining2 7#f7 in subsection 7f7-- 7,a7 in paragraph 7#a7-- 7i7 in subparagraph 7,b71 by striking misuse of a schedule ,,ii1 ,,iii1 or ,,iv substance and inserting misuse of a controlled substance included in schedule ,,ii1 ,,iii1 or ,,iv of section #bjb7;c7 of the ,controlled ,substance ,act2 and 7ii7 in subparagraph 7,d71 by inserting a ,state substance abuse agency1 after a ,state health department12 and 7,b7 by adding at the end the following3 7#c7 ,evaluation and reporting ,subject to subsection 7g71 a ,state receiving a grant under subsection 7a7 shall provide the ,secretary with aggregate data and other information determined by the ,secretary to be necessary to enable the ,secretary-- 7,a7 to evaluate the success of the ,state's program in achieving its purposes2 or 7,b7 to prepare and submit the report to ,congress required by subsection 7l77#b74 7#d7 ,research by other entities ,a department1 program1 or administration receiving nonidentifiable information under paragraph 7#a77;,d7 may make such information available to other entities for research purposes4 2 7#g7 by redesignating subsections 7h7 through 7n7 as subsections 7j7 through 7p71 respectively2 7#h7 in subsections 7c77#a77;,a77iv7 and 7d77#d71 by striking subsection 7h7 each place it appears and inserting subsection 7j72 7#i7 by inserting after subsection 7g7 the following3 7h7 ,education and access to the monitoring system ,a ,state receiving a grant under subsection 7a7 shall take steps to-- 7#a7 facilitate prescriber and dispenser use of the ,state's controlled substance monitoring system2 7#b7 educate prescribers and dispensers on the benefits of the system both to them and society2 and 7#c7 facilitate linkage to the ,state substance abuse agency and substance abuse disorder services4 7i7 ,consultation with ,attorney ,general ,in carrying out this section1 the ,secretary shall consult with the ,attorney ,general of the ,united ,states and other relevant ,federal officials to-- 7#a7 ensure maximum coordination of controlled substance monitoring programs and related activities2 and 7#b7 minimize duplicative efforts and funding4 2 7#aj7 in subsection 7l77#b77;,a71 as redesignated by paragraph 7#g7-- 7,a7 in clause 7ii71 by inserting 2 established or strengthened initiatives to ensure linkages to substance use disorder services2 before or affected patient access2 and 7,b7 in clause 7iii71 by inserting and between controlled substance monitoring programs and health information technology systems1 before 1 including an assessment2 7#aa7 by striking subsection 7m7 7relating to preference71 as redesignated by paragraph 7#g72 7#ab7 by redesignating subsections 7m7 through 7o71 as redesignated by paragraph 7#g71 as subsections 7l7 through 7o71 respectively2 7#ac7 in subsection 7m77#a71 as redesignated by paragraph 7#ab71 by striking establishment1 implementation1 or improvement and inserting establishment1 improvement1 or maintenance2 7#ad7 in subsection 7n7-- 7,a7 in paragraph 7#e7-- 7i7 by striking means the ability and inserting the following3 means-- 7,a7 the ability 2 7ii7 by striking the period at the end and inserting 2 or2 and 7iii7 by adding at the end the following3 7,b7 sharing of ,state controlled substance monitoring program information with a health information technology system such as an electronic health records system1 a health information exchange1 or an e-prescribing system4 2 7,b7 in paragraph 7#g71 by striking pharmacy and inserting pharmacist2 and 7,c7 in paragraph 7#h71 by striking and the ,district of ,columbia and inserting 1 the ,district of ,columbia1 and any commonwealth or territory of the ,united ,states2 and 7#ae7 by amending subsection 7o71 as redesignated by paragraph 7#ab71 to read as follows3 7o7 ,authorization of appropriations ,to carry out this section1 there is authorized to be appropriated #aj1jjj1jjj for each of fiscal years from #bjaf through #bjbj4 4 #aj4 ,offset ,it is the sense of ,congress that the amounts expended to carry out this ,act and the amendments made by this ,act should be offset by a corresponding reduction in ,federal discretionary spending4